These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 7552250

  • 1. The effect of chronic treatment with a novel aryl-piperazine antipsychotic on monoamine receptors in rat brain.
    Shapiro LA, Offord SJ, Ordway GA.
    Brain Res; 1995 Apr 24; 677(2):250-6. PubMed ID: 7552250
    [Abstract] [Full Text] [Related]

  • 2. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
    Tarazi FI, Florijn WJ, Creese I.
    Neuroscience; 1997 Jun 24; 78(4):985-96. PubMed ID: 9174067
    [Abstract] [Full Text] [Related]

  • 3. Chronic haloperidol alters dopamine receptors: effects of cocaine exposure during the preweaning period.
    Shi X, Yin R, Dow-Edwards D.
    Eur J Pharmacol; 1999 Apr 16; 370(3):241-9. PubMed ID: 10334498
    [Abstract] [Full Text] [Related]

  • 4. Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.
    Inoue A, Miki S, Seto M, Kikuchi T, Morita S, Ueda H, Misu Y, Nakata Y.
    Eur J Pharmacol; 1997 Feb 19; 321(1):105-11. PubMed ID: 9083792
    [Abstract] [Full Text] [Related]

  • 5. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 19; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 6. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies.
    Huang N, Ase AR, Hébert C, van Gelder NM, Reader TA.
    Neurochem Int; 1997 Mar 19; 30(3):277-90. PubMed ID: 9041559
    [Abstract] [Full Text] [Related]

  • 7. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G.
    Exp Neurol; 1997 Jul 19; 146(1):74-80. PubMed ID: 9225740
    [Abstract] [Full Text] [Related]

  • 8. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 19; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 9. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C, Carilla-Durand E, Assié MB, Ormiere AM, Maraval M, Leduc N, Newman-Tancredi A.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):135-44. PubMed ID: 16554049
    [Abstract] [Full Text] [Related]

  • 10. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA, Szczepanik AM.
    Brain Res; 1989 May 22; 487(2):288-98. PubMed ID: 2525063
    [Abstract] [Full Text] [Related]

  • 11. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum.
    Ishikane T, Kusumi I, Matsubara R, Matsubara S, Koyama T.
    Eur J Pharmacol; 1997 Feb 26; 321(2):163-9. PubMed ID: 9063684
    [Abstract] [Full Text] [Related]

  • 12. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus.
    Flores G, Barbeau D, Quirion R, Srivastava LK.
    J Neurosci; 1996 Mar 15; 16(6):2020-6. PubMed ID: 8604046
    [Abstract] [Full Text] [Related]

  • 13. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.
    Roglić G, Dukić-Stefanović S, Andrić D, Kostić-Rajacić S, Soskić V.
    Pharmazie; 2001 Oct 15; 56(10):803-7. PubMed ID: 11683128
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of several substituted phenylpiperazines behaving as mixed D2/5HT1A ligands.
    Dukić S, Kostić-Rajacić S, Dragović D, Soskić V, Joksimović J.
    J Pharm Pharmacol; 1997 Oct 15; 49(10):1036-41. PubMed ID: 9364416
    [Abstract] [Full Text] [Related]

  • 15. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.
    See RE, Lynch AM, Sorg BA.
    Neuroscience; 1996 May 15; 72(1):99-104. PubMed ID: 8730709
    [Abstract] [Full Text] [Related]

  • 16. PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects.
    Akunne HC, Zoski KT, Davis MD, Cooke LW, Meltzer LT, Whetzel SZ, Shih YH, Wustrow DJ, Wise LD, MacKenzie RG, Georgic LM, Heffner TG, Pugsley TA.
    Neuropharmacology; 2000 Apr 27; 39(7):1197-210. PubMed ID: 10760362
    [Abstract] [Full Text] [Related]

  • 17. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
    Sumiyoshi T, Ichikawa J, Meltzer HY.
    Neuropsychopharmacology; 1997 Mar 27; 16(3):183-90. PubMed ID: 9138434
    [Abstract] [Full Text] [Related]

  • 18. Regional brain changes in [3H]SCH 23390 binding to dopamine D1, receptors after long-term haloperidol treatment: lack of correspondence with the development of vacuous chewing movements.
    Sasaki T, Kennedy JL, Nobrega JN.
    Behav Brain Res; 1998 Feb 27; 90(2):125-32. PubMed ID: 9521545
    [Abstract] [Full Text] [Related]

  • 19. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
    Schotte A, Janssen PF, Megens AA, Leysen JE.
    Brain Res; 1993 Dec 24; 631(2):191-202. PubMed ID: 7510574
    [Abstract] [Full Text] [Related]

  • 20. Structure-affinity relationship studies on D-2/5-HT1A receptor ligands. 4-(2-Heteroarylethyl)-1-arylpiperazines.
    Dukić S, Vujović M, Soskić V, Joksimović J.
    Arzneimittelforschung; 1997 Mar 24; 47(3):239-43. PubMed ID: 9105540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.